jrnls.org logo
Submit

BROWSE ALL JOURNALS

Type 2 letters to search all 19 journals

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Back

IJPER · Lens · The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia

PDF

Article · Volume 56, Issue 4 · pp. 1226–1231

The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia

Mazen Almehmadi1, Magdi Salih1, Ayman Al-hazmi1, Muhannad Alenazi1, Osama Abdulaziz1, Faisal Almalki1, Alaa Shafie1, Naif Alsiwiehri1, Mamdouh Allahyani1, Njoud Althibity2, Ebtisam Alosimi2, Abdullah Turjoman5, Fatimah Rebh3, Abdulelah Aljuaid1, Mustafa Halawi4

  1. 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.
  2. 2Department of Chemistry, College of Sciences, Taif University, Taif, SAUDI ARABIA.
  3. 3Department of Internal Medicine, Section of Infectious Diseases, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.
  4. 4Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, SAUDI ARABIA.
  5. 5Department of Clinical Laboratory, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.

Abstract

Objectives: The aim of this study was to estimate the prevalence of anemia among COVID-19 patients in Saudi Arabia and evaluate their hematological parameters.Materials and Methods: A descriptive, cross-sectional, hospital-based study was conducted between February 2021 to March 2021, data collection covered the period between September 2020 to March 2021. All the patients were hospitalized for confirmed COVID-19.Results: A total of 6048 COVID-19 patients included in our study, 2358 (48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%) were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median (interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to 14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female (interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/ dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological parameters detected are indicative of severe complications in anemic patients compared to non-anemic patients.Conclusion: Our findings were consistent with other studies that reported poor outcomes of anemia in COVID-19 patients.

Keywords: Anemia; Polycythemia; COVID-19; Hematological factors; CBC

The full text of this article is available as a PDF. Open the PDF.